supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“Treatment of the pancreatic beta-cell line betaTC6-F7 with an imidazoline compound, RX-871024, KCl, or tolbutamide resulted in increased threonine phosphorylation of a 220-kDa protein (p220) concurrent with enhanced insulin secretion, which can be partially antagonized by diazoxide , an ATP-sensitive potassium (K(ATP)) channel activator.”
Threonine phosphorylations induced by RX-871024 and insulin secretagogues in betaTC6-F7 cells.“Treatment of the pancreatic β-cell line βTC6-F7 with an imidazoline compound, RX-871024, KCl, or tolbutamide resulted in increased threonine phosphorylation of a 220-kDa protein (p220) concurrent with enhanced insulin secretion, which can be partially antagonized by diazoxide , an ATP-sensitive potassium (KATP) channel activator.”
Threonine phosphorylations induced by RX-871024 and insulin secretagogues in βTC6-F7 cells.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback